The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.

The latest price target for Carter Bankshares (NASDAQ: CARE) was reported by Raymond James on May 1, 2023. The analyst firm set a price target for $17.00 expecting CARE to rise to within 12 months (a possible 35.67% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter Bankshares (NASDAQ: CARE) was provided by Raymond James, and Carter Bankshares upgraded their outperform rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on May 1, 2023 so you should expect the next rating to be made available sometime around May 1, 2024.

While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a upgraded with a price target of $0.00 to $17.00. The current price Carter Bankshares (CARE) is trading at is $12.53, which is within the analyst’s predicted range.